Researchers from Stanford (Calif.) University are enrolling 200 participants in a phase 2 study to see if Paxlovid could be used to treat the millions of Americans experiencing long COVID-19, according to a Nov. 21 entry on clinicaltrials.gov.
Read the full post on Becker's Hospital Review - Healthcare News
